💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Coherus BioSciences, Inc. (CHRS)
« Back to company indexCHRS Chatter Timeline
Stock Ticker for CHRS
Most Active Tweeters for CHRS
| User | Tweets |
|---|---|
| @ShortAlgoKing | 8 |
| @Tickeron | 3 |
| @Ba4Saso | 2 |
| @ShogunTrade | 2 |
| @mediasentiment | 2 |
Recent Tweets for CHRS
 |
@DeepSouthDoctor Bought $CHRS. Not a "sexy" name, but IMHO the single best long-term, de-risked value among SMID-cap bios. At $12 &… https://t.co/6OMrmHVpEr January 25th 2022, 6:01pm |
 |
@larrywabrams $CHRS at $12/s it is at a 3 year low. No new revenue for 2022. Pegfilgrastim market increasing price competition .… https://t.co/5Vp4anSbWl January 25th 2022, 4:01pm |
 |
@bkfViking123 RT @bkfViking123: $chrs 2x bottom https://t.co/1unqY7EOsF January 25th 2022, 3:01am |
 |
@Tickeron A.I.dvisor made a bearish call on $CHRS, netting in a 26.19% gain over 3 months #CoherusBioSciences… https://t.co/L8Z3NzgveU January 25th 2022, 2:01am |
 |
@A1Syad $CHRS Waiting for Buy signal. Chart by https://t.co/1MjnDHV7ua https://t.co/AQhAZfOkN5 January 24th 2022, 5:01pm |
 |
@ShortAlgoKing $CHRS The chart is demonstrating a bearish pattern. Waiting for buy signal ?! Get access to UltraAlgo for simplifi… https://t.co/RrLujH2cXE January 24th 2022, 1:01pm |
 |
@MaiteMerenda $CHRS Awaiting Buy Signal. Chart by https://t.co/t5kOjgsWN3 https://t.co/f9jIyfRyBl January 24th 2022, 11:01am |
|
@bkfViking123 $chrs 2x bottom https://t.co/1unqY7EOsF January 24th 2022, 5:01am |
 |
@Ba4Saso $CHRS Watching for Buy Signal. Chart by https://t.co/z6vAd7dl0q https://t.co/QBilbYffG5 January 23rd 2022, 12:01pm |
 |
@ChartMill $CHRS was analyzed by 13 analysts. The buy consensus is at 80%. So analysts seem to be mildly confident about $ ...… https://t.co/XBnd6yFHni January 23rd 2022, 2:01am |
 |
@hesham_monica $CHRS Awaiting Buy Signal. Free Trial https://t.co/wUyihfppva https://t.co/RRK6Ve5Yzc January 21st 2022, 8:01pm |
|
@ShortAlgoKing $CHRS Monitoring for a buy entry with UltraAlgo. Get access to UltraAlgo for simplified Buy / Sell signals. Reg… https://t.co/re6qT4rdIw January 21st 2022, 1:01pm |
 |
@ValueDig @adar170 Which one do you like better $EQRX vs $CHRS January 20th 2022, 11:01pm |
|
@ShortAlgoKing $CHRS Monitoring for a buy entry with UltraAlgo. Get access to UltraAlgo for simplified Buy / Sell signals. Reg… https://t.co/zJdjVcyenB January 20th 2022, 1:01pm |
|
@ShortAlgoKing $CHRS Monitoring for a buy entry with UltraAlgo. Get access to UltraAlgo for simplified Buy / Sell signals. Reg… https://t.co/SZKpatrbba January 19th 2022, 11:01am |
 |
@StckPro $CHRS NEW ARTICLE : Mizuho Securities Thinks Coherus Biosciences’ Stock is Going to Recover https://t.co/zGeHZmm4Ok… https://t.co/AMslagdSY5 January 19th 2022, 12:01am |
 |
@ShogunTrade $CHRS Awaiting Buy Signal. Chart by https://t.co/6vnULU2sSf . https://t.co/4uAXpNoV0x January 18th 2022, 10:01pm |
 |
@TradeWithAlerts Nice print for $CHRS Size: 261137 Price: 13.23 Amount: $3,454,842.51 Time: 1600 See more: https://t.co/kuGZVbXujK J… https://t.co/PCf5kI8ubI January 18th 2022, 9:01pm |
 |
@ShortAlgoTrades $CHRS Bullish pattern building. Chart by https://t.co/jpmUt7BvVp https://t.co/USdEaxrPQ3 January 18th 2022, 7:01pm |
|
@ShortAlgoKing $CHRS The chart is demonstrating a bearish pattern. Waiting for buy signal ?! Get access to UltraAlgo for simplifi… https://t.co/pq9danYpOR January 18th 2022, 12:01pm |
 |
@VatqLu $CHRS Waiting for Buy signal. https://t.co/seIXUCtldW January 17th 2022, 8:01pm |
|
@Tickeron $CHRS enters a Downtrend because Momentum Indicator dropped below the 0 level on December 30, 2021. View odds for t… https://t.co/AokBzfptTS January 15th 2022, 8:01pm |
|
@Ba4Saso $CHRS Awaiting Buy Signal. Free 7 Day Trial at https://t.co/z6vAd7dl0q https://t.co/cICFzdAV0M January 15th 2022, 8:01pm |
 |
@MarcJacksonLA $CHRS Coherus BioSciences Expected to Announce Earnings of -$0.61 Per Share | https://t.co/NKb5pRLCDo https://t.co/e5M3v3GaV7 January 15th 2022, 4:01pm |
|
@TradeWithAlerts Nice print for $CHRS Size: 126215 Price: 13.9 Amount: $1,754,388.50 Time: 1600 See more: https://t.co/kuGZVbFSVa Jo… https://t.co/y0iwKDrfZQ January 14th 2022, 9:01pm |
 |
@Aesculapius1898 @Biohazard3737 Besides $CHRS..what catches your eye? January 14th 2022, 8:01pm |
|
@hesham_monica $CHRS Awaiting Buy Signal. Free Trial https://t.co/wUyihfppva https://t.co/i46ljgEU1I January 14th 2022, 6:01pm |
|
@ShogunTrade $CHRS Awaiting Buy Signal. Chart by https://t.co/6vnULU2sSf https://t.co/INPxwCOwd5 January 14th 2022, 1:01pm |
|
@ShortAlgoKing $CHRS Monitoring for a buy entry with UltraAlgo. Get access to UltraAlgo for simplified Buy / Sell signals. Reg… https://t.co/G6zraWX20c January 14th 2022, 11:01am |
|
@Tickeron $CHRS's price moved below its 50-day Moving Average on December 28, 2021. View odds for this and other indicators:… https://t.co/xWaFDiO16s January 14th 2022, 4:01am |
 |
@Biohazard3737 @PreparedRemarks @tomicki 1Bn market cap. I think they could have $500M in annual free cash flow in 2025. $CHRS January 14th 2022, 3:01am |
|
@Biohazard3737 @PreparedRemarks @tomicki If you want real products at an absurd price, take a look at $CHRS. January 14th 2022, 3:01am |
 |
@investor_feed $CHRS 8-K Coherus Biosciences (13 Jan, 4:39pm) ? Entry into a Material Definitive Agreement; Other Events… https://t.co/ajSwTlX5Kh January 13th 2022, 9:01pm |
|
@ShortAlgoKing $CHRS Almost ripe for a jump! Chart by https://t.co/qchl9O5K2n https://t.co/kyMk3WzIgU January 13th 2022, 9:01pm |
|
@VatqLu $CHRS Waiting for Buy signal https://t.co/ap9fWgMDJ9 January 13th 2022, 3:01pm |
|
@A1Syad $CHRS Awaiting Buy Signal. Free Trial at https://t.co/1MjnDHV7ua https://t.co/8VLFU5GfJx January 13th 2022, 2:01pm |
|
@investor_feed $CHRS S-8 Coherus Biosciences (13 Jan, 6:06am) ? Registration Statement on Form S-8 https://t.co/8NuhZwz153… https://t.co/BAew5aYaYu January 13th 2022, 11:01am |
 |
@InsiderAlerts4U $CHRS: New Insider Filing on Coherus BioSciences, Inc.'s Chief Scientific Officer VLADIMIR VEXLER: https://t.co/UMap516fRz January 13th 2022, 1:01am |
 |
@kshahi Just listened to $CHRS JPM conf presentation. Real opportunity here imo. May take 4-12 months. #timestamp January 13th 2022, 12:01am |
 |
@FlashAlert_me $CHRS [15s. delayed] filed SEC form 4: Chief Scientific Officer Vexler Vladimir: Delivered securities 7,733 of Com… https://t.co/flUG5OH3tL January 12th 2022, 9:01pm |
 |
@SeekingAlpha $CHRS - Coherus BioScience (CHRS) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference.… https://t.co/TiRcA6OMlG January 12th 2022, 8:01pm |
 |
@saltydogstocks $CHRS https://t.co/WTUCtbORTe January 12th 2022, 8:01pm |
|
@ShortAlgoKing $CHRS The chart is demonstrating a bearish pattern. Waiting for buy signal ?! Get access to UltraAlgo for simplifi… https://t.co/BPwAlySIl9 January 12th 2022, 3:01pm |
 |
@mediasentiment $CHRS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 136 January 12th 2022, 10:01am |
|
@mediasentiment $CHRS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 135 January 12th 2022, 10:01am |
|
@InsiderAlerts4U $CHRS: New Insider Filing on Coherus BioSciences, Inc.'s Director MARK STOLPER: https://t.co/TnRhn2CQjK January 11th 2022, 4:01pm |
 |
@TamifluFighters RT @MattBiotech: $CHRS has a pretty impressive next two years ahead of it if they can really execute everything they are promising. My note… January 11th 2022, 4:01pm |
 |
@MattBiotech $CHRS has a pretty impressive next two years ahead of it if they can really execute everything they are promising.… https://t.co/CRI1NgAiZa January 11th 2022, 4:01pm |
|
@InsiderAlerts4U $CHRS: New Insider Filing on Coherus BioSciences, Inc.'s Director MATS WAHLSTROM: https://t.co/an0M5OOVTW January 11th 2022, 12:01pm |
|
@StckPro $CHRS NEW ARTICLE : H.C. Wainwright Sticks to Their Buy Rating for Coherus Biosciences (CHRS)… https://t.co/b4FTIaDsDL January 11th 2022, 11:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?